The 8 references in paper Elena Titova A., Elena Reutskaya M., Andrey Eyrikh R., Е. Титова А., Е. Реуцкая М., А. Эйрих Р. (2017) “Пресепсин – маркер сепсиса и тяжелой пневмонии // Presepsin as a marker of sepsis and severe pneumonia” / spz:neicon:pulmonology:y:2017:i:3:p:366-370

1
Чучалин А.Г. Биологические маркеры при респираторных заболеваниях.Терапевтический архив.2014; 86 (3): 4–13.
(check this in PDF content)
2
Вельков В.В. Использование биомаркера «Пресепсин» для ранней и высокоспецифической диагностики сепсиса. Клинические рекомендации. М.; 2014. Доступно на: http://www.fedlab.ru/upload/medialibrary/e5e/kochetov'ag. 'klin'rek.'kld.'presepsin_'dek'2014. pdf(дата обращения 02.02.17).
(check this in PDF content)
3
Behnes M., Bertsch T., Lepiorz D. et al. Diagnostic and prognostic utility of CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit. Care. 2014, 18 (5): 507. DOI: 10.1186/ s13054-014-0507-z.
(check this in PDF content)
4
Чучалин А. Г., Синопальников А.И., Козлов Р.С. и др. Клинические рекомендации по диагностике, лечению и профилактике тяжелой внебольничной пневмонии у взрослых. М., 2014. Доступно на: http://nii.pulmonology. ru/resources/guide.php (дата обращения 02.02.17).
(check this in PDF content)
5
Shozushima T., Takahashi G., Matsumoto N. et al. Usefulness of presepsin (sCD 14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J. Infect. Chemother.2011; 17 (6): 764–769. DOI: 10.1007/ s10156-011-0254-x. 2Spanuth E., Giannitsis E. Diagnosis of sepsis and monitoring of weaning from mechanical ventilation in critical ill patients by PATHFASTP resepsin. 20thIFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, May 19 – 23, 2013, Milano, Italy. TO22. http://journal.pulmonology.ru/pulm Титова Е.А. и др.Пресепсин – маркер сепсиса и тяжелой пневмонии
(check this in PDF content)
6
Saito J., Hashiba E., Kushikata T. et al. Changes in pre1. Chuchalin A.G. Biological markers in respiratory diseases. Terapevticheskiy arkhiv.2014; 86 (3): 4–13 (in Russian). 2. Vel'kov V.V. Use of Presepsin as an Early and High-Specific Diagnostic Biomarker of Sepsis. Moscow; 2014. Available at: http://www.fedlab.ru/upload/medialibrary/e5e/kochetov' ag.'klin'rek.'kld.'presepsin_'dek'2014.pdf(in Russian). 3. Behnes M., Bertsch T., Lepiorz D. et al. Diagnostic and prognostic utility of CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit. Care. 2014, 18 (5): 507. DOI: 10.1186/ s13054-014-0507-z. 4. Chuchalin A.G., Sinopal'nikov A.I., Kozlov R.S. et al. Clinical Guidelines o
(check this in PDF content)
7
Zhang J., Hu Z., Song J. et al. Diagnostic value of presepsin for sepsis. Medicine. 2015; 94 (47): e2158. DOI: 10.1097/ md.0000000000002158.
(check this in PDF content)
8
Liu B., Yin Q., Chen Y.X. et al. Role of Presepsin (sCD14ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department. Respir. Med. 2014; 108 (8): 1204– 1213. DOI: 10.1016/j.med.2014.05.005. Received Januar
(check this in PDF content)